This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Here's Why You Should Hold Onto Ingevity (NGVT) Stock Now
by Zacks Equity Research
Let's find out why specialty chemicals and materials maker Ingevity (NGVT) is worth retaining at the moment.
Dow Expands Hand Sanitizer Production to Combat Coronavirus
by Zacks Equity Research
Dow's (DOW) current manufacturing facilities are crucial to supply several important sanitation and medical products and technologies to better tackle the coronavirus pandemic.
Air Products Inks Deal to Buy Five Hydrogen Plants for $530M
by Zacks Equity Research
Air Products (APD) expects the deal to close in the third quarter of fiscal 2020.
What Makes Daqo New Energy (DQ) a Solid Choice Right Now
by Zacks Equity Research
Let's see why leading polysilicon producer Daqo New Energy (DQ) is a compelling investment option at the moment.
LyondellBasell (LYB) Delays the PO/TBA Project Construction
by Zacks Equity Research
Considering the current concerns related to the coronavirus pandemic, LyondellBasell (LYB) is limiting non-essential activities.
Cabot (CBT) Withdraws FY20 View Amid Coronavirus Pandemic
by Zacks Equity Research
Cabot (CBT) expects financial results to be solid for the fiscal second quarter. However, it is withdrawing the previous financial guidance for fiscal 2020.
Why Should You Hold Onto Kronos Worldwide (KRO) for Now?
by Zacks Equity Research
Kronos Worldwide (KRO) is poised to gain from healthy long-term demand for titanium dioxide (TiO2).
U.S. Steel to Prioritize Cash Flows Amid Coronavirus Pandemic
by Zacks Equity Research
U.S. Steel (X) to maintain strategic flexibility by prioritizing cash and liquidity.
Air Products to Build Gasunie's 3 Nitrogen Plants in Zuidbroek
by Zacks Equity Research
Air Products (APD) will build three plants for Gasunie to produce nitrogen required to meet the specifications of commercial and consumer applications across the country.
Scotts Miracle-Gro (SMG) Announces Preliminary Results for Q2
by Zacks Equity Research
Scotts Miracle-Gro (SMG) is witnessing a sharp rise in demand in March, which is expected to boost consumer purchases by nearly 25% in the fiscal second quarter.
Univar Provides Business Update Amid Coronavirus Outbreak
by Zacks Equity Research
Univar (UNVR) plans to offer a revised outlook for 2020, once it gets more clarity on the implications of the coronavirus outbreak on its business.
U.S. Silica (SLCA) to Reduce Annualized SG&A Costs by $20M
by Zacks Equity Research
U.S. Silica's (SLCA) latest move is in response to the decrease in oil prices as well as an expected decline in drilling and completion activities in North American shale.
Eastman Highlights Financial Position Amid Coronavirus Concern
by Zacks Equity Research
Eastman Chemical (EMN) anticipates first-quarter 2020 earnings per share to rise from the prior-year period.
Vale Idles Malaysia Port, Declares Aid for Suppliers in Brazil
by Zacks Equity Research
Vale S.A (VALE) temporarily closes its Malaysian terminal and distribution center, and announces support initiatives for its suppliers in Brazilin the wake of the coronavirus outbreak.
CF Industries (CF) Poised on Higher Demand Amid Pricing Woes
by Zacks Equity Research
CF Industries (CF) is expected to benefit from higher nitrogen fertilizer demand and lower natural gas costs amid headwinds from weak product prices.
Agnico Eagle Withdraws 2020 View Amid Coronavirus Pandemic
by Zacks Equity Research
Agnico Eagle (AEM) decides to lower production activities at the Quebec and Nunavut operations.
Here's Why You Should Hold Onto Chemours (CC) Stock Now
by Zacks Equity Research
Chemours (CC) should gain from its actions to drive Opteon adoption and boost productivity across its business segments in 2020.
Teck Modifies Fort Hills Operating Plan Amid Low Oil Prices
by Zacks Equity Research
Teck's (TECK) share of Fort Hills production likely to be down by 8-9 million barrels of bitumen for the current year.
Ingevity Provides Update in Response to Coronavirus Outbreak
by Zacks Equity Research
Ingevity's (NGVT) first quarter is going better than anticipated despite modest headwinds from the coronavirus outbreak.
Air Products Inks Another Oxy-Fuel Contract With Techpack
by Zacks Equity Research
Air Products (APD) will supply the oxygen and combustion systems needed by Techpack at its manufacturing complex when the project comes onstream.
Century Aluminum (CENX) Issues Update on Coronavirus Response
by Zacks Equity Research
Century Aluminum (CENX) is implementing various measures such as lowering its cost structure in response to the pandemic.
DuPont (DD) Introduces Laminex Maxflow 4G Enzyme in Australia
by Zacks Equity Research
DuPont's (DD) Laminex Maxflow 4G is highly effective in lowering pentosan levels in all wort forms.
Dow (DOW) Introduces Innovations for Water-Based Coatings
by Zacks Equity Research
Dow's (DOW) innovations are expected to help its customers boost the competitiveness of their formulations.
Freeport to Suspend Cash Dividend, Aims to Boost Cash Flows
by Zacks Equity Research
Freeport (FCX) is reviewing its global copper and molybdenum operations to reduce costs and capital expenditure, and achieve the maximum cash flow in the current market conditions.
Newmont (NEM) Withdraws 2020 View Amid Coronavirus Pandemic
by Zacks Equity Research
For the first quarter, Newmont (NEM) expects to produce around 1.4 million attributable gold ounces.